SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification

Takako Hattori, Catharina Müller, Sonja Gebhard, Eva Bauer, Friederike Pausch, Britta Schlund, Michael R. Bösl, Andreas Hess, Cordula Surmann-Schmitt, Helga Von Der Mark, Benoit De Crombrugghe, Klaus Von Der Mark

Research output: Contribution to journalArticle

143 Citations (Scopus)

Abstract

SOX9 is a transcription factor of the SRY family that regulates sex determination, cartilage development and numerous other developmental events. In the foetal growth plate, Sox9 is highly expressed in chondrocytes of the proliferating and prehypertrophic zone but declines abruptly in the hypertrophic zone, suggesting that Sox9 downregulation in hypertrophic chondrocytes might be a necessary step to initiate cartilage-bone transition in the growth plate. In order to test this hypothesis, we generated transgenic mice misexpressing Sox9 in hypertrophic chondrocytes under the control of a BAC-Col10a1 promoter. The transgenic offspring showed an almost complete lack of bone marrow in newborns, owing to strongly retarded vascular invasion into hypertrophic cartilage and impaired cartilage resorption, resulting in delayed endochondral bone formation associated with reduced bone growth. In situ hybridization analysis revealed high levels of Sox9 misexpression in hypertrophic chondrocytes but deficiencies of Vegfa, Mmp13, RANKL and osteopontin expression in the non-resorbed hypertrophic cartilage, indicating that Sox9 misexpression in hypertrophic chondrocytes inhibits their terminal differentiation. Searching for the molecular mechanism of SOX9-induced inhibition of cartilage vascularization, we discovered that SOX9 is able to directly suppress Vegfa expression by binding to SRY sites in the Vegfa gene. Postnatally, bone marrow formation and cartilage resorption in transgenic offspring are resumed by massive invasion of capillaries through the cortical bone shaft, similar to secondary ossification. These findings imply that downregulation of Sox9 in the hypertrophic zone of the normal growth plate is essential for allowing vascular invasion, bone marrow formation and endochondral ossification.

Original languageEnglish
Pages (from-to)901-911
Number of pages11
JournalDevelopment
Volume137
Issue number6
DOIs
Publication statusPublished - Mar 15 2010

Fingerprint

Osteogenesis
Cartilage
Bone Marrow
Chondrocytes
Growth Plate
Blood Vessels
Down-Regulation
Osteopontin
Bone Development
Fetal Development
Transgenic Mice
In Situ Hybridization
Transcription Factors
Bone and Bones
Genes

Keywords

  • BAC
  • Collagen X
  • Mmp13
  • Mouse
  • Runx2
  • Transgenic
  • Vegfa

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Medicine(all)

Cite this

SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification. / Hattori, Takako; Müller, Catharina; Gebhard, Sonja; Bauer, Eva; Pausch, Friederike; Schlund, Britta; Bösl, Michael R.; Hess, Andreas; Surmann-Schmitt, Cordula; Von Der Mark, Helga; De Crombrugghe, Benoit; Von Der Mark, Klaus.

In: Development, Vol. 137, No. 6, 15.03.2010, p. 901-911.

Research output: Contribution to journalArticle

Hattori, T, Müller, C, Gebhard, S, Bauer, E, Pausch, F, Schlund, B, Bösl, MR, Hess, A, Surmann-Schmitt, C, Von Der Mark, H, De Crombrugghe, B & Von Der Mark, K 2010, 'SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification', Development, vol. 137, no. 6, pp. 901-911. https://doi.org/10.1242/dev.045203
Hattori, Takako ; Müller, Catharina ; Gebhard, Sonja ; Bauer, Eva ; Pausch, Friederike ; Schlund, Britta ; Bösl, Michael R. ; Hess, Andreas ; Surmann-Schmitt, Cordula ; Von Der Mark, Helga ; De Crombrugghe, Benoit ; Von Der Mark, Klaus. / SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification. In: Development. 2010 ; Vol. 137, No. 6. pp. 901-911.
@article{2ebeeb5f62dd4f238ce3ea03246b301e,
title = "SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification",
abstract = "SOX9 is a transcription factor of the SRY family that regulates sex determination, cartilage development and numerous other developmental events. In the foetal growth plate, Sox9 is highly expressed in chondrocytes of the proliferating and prehypertrophic zone but declines abruptly in the hypertrophic zone, suggesting that Sox9 downregulation in hypertrophic chondrocytes might be a necessary step to initiate cartilage-bone transition in the growth plate. In order to test this hypothesis, we generated transgenic mice misexpressing Sox9 in hypertrophic chondrocytes under the control of a BAC-Col10a1 promoter. The transgenic offspring showed an almost complete lack of bone marrow in newborns, owing to strongly retarded vascular invasion into hypertrophic cartilage and impaired cartilage resorption, resulting in delayed endochondral bone formation associated with reduced bone growth. In situ hybridization analysis revealed high levels of Sox9 misexpression in hypertrophic chondrocytes but deficiencies of Vegfa, Mmp13, RANKL and osteopontin expression in the non-resorbed hypertrophic cartilage, indicating that Sox9 misexpression in hypertrophic chondrocytes inhibits their terminal differentiation. Searching for the molecular mechanism of SOX9-induced inhibition of cartilage vascularization, we discovered that SOX9 is able to directly suppress Vegfa expression by binding to SRY sites in the Vegfa gene. Postnatally, bone marrow formation and cartilage resorption in transgenic offspring are resumed by massive invasion of capillaries through the cortical bone shaft, similar to secondary ossification. These findings imply that downregulation of Sox9 in the hypertrophic zone of the normal growth plate is essential for allowing vascular invasion, bone marrow formation and endochondral ossification.",
keywords = "BAC, Collagen X, Mmp13, Mouse, Runx2, Transgenic, Vegfa",
author = "Takako Hattori and Catharina M{\"u}ller and Sonja Gebhard and Eva Bauer and Friederike Pausch and Britta Schlund and B{\"o}sl, {Michael R.} and Andreas Hess and Cordula Surmann-Schmitt and {Von Der Mark}, Helga and {De Crombrugghe}, Benoit and {Von Der Mark}, Klaus",
year = "2010",
month = "3",
day = "15",
doi = "10.1242/dev.045203",
language = "English",
volume = "137",
pages = "901--911",
journal = "Development (Cambridge)",
issn = "0950-1991",
publisher = "Company of Biologists Ltd",
number = "6",

}

TY - JOUR

T1 - SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification

AU - Hattori, Takako

AU - Müller, Catharina

AU - Gebhard, Sonja

AU - Bauer, Eva

AU - Pausch, Friederike

AU - Schlund, Britta

AU - Bösl, Michael R.

AU - Hess, Andreas

AU - Surmann-Schmitt, Cordula

AU - Von Der Mark, Helga

AU - De Crombrugghe, Benoit

AU - Von Der Mark, Klaus

PY - 2010/3/15

Y1 - 2010/3/15

N2 - SOX9 is a transcription factor of the SRY family that regulates sex determination, cartilage development and numerous other developmental events. In the foetal growth plate, Sox9 is highly expressed in chondrocytes of the proliferating and prehypertrophic zone but declines abruptly in the hypertrophic zone, suggesting that Sox9 downregulation in hypertrophic chondrocytes might be a necessary step to initiate cartilage-bone transition in the growth plate. In order to test this hypothesis, we generated transgenic mice misexpressing Sox9 in hypertrophic chondrocytes under the control of a BAC-Col10a1 promoter. The transgenic offspring showed an almost complete lack of bone marrow in newborns, owing to strongly retarded vascular invasion into hypertrophic cartilage and impaired cartilage resorption, resulting in delayed endochondral bone formation associated with reduced bone growth. In situ hybridization analysis revealed high levels of Sox9 misexpression in hypertrophic chondrocytes but deficiencies of Vegfa, Mmp13, RANKL and osteopontin expression in the non-resorbed hypertrophic cartilage, indicating that Sox9 misexpression in hypertrophic chondrocytes inhibits their terminal differentiation. Searching for the molecular mechanism of SOX9-induced inhibition of cartilage vascularization, we discovered that SOX9 is able to directly suppress Vegfa expression by binding to SRY sites in the Vegfa gene. Postnatally, bone marrow formation and cartilage resorption in transgenic offspring are resumed by massive invasion of capillaries through the cortical bone shaft, similar to secondary ossification. These findings imply that downregulation of Sox9 in the hypertrophic zone of the normal growth plate is essential for allowing vascular invasion, bone marrow formation and endochondral ossification.

AB - SOX9 is a transcription factor of the SRY family that regulates sex determination, cartilage development and numerous other developmental events. In the foetal growth plate, Sox9 is highly expressed in chondrocytes of the proliferating and prehypertrophic zone but declines abruptly in the hypertrophic zone, suggesting that Sox9 downregulation in hypertrophic chondrocytes might be a necessary step to initiate cartilage-bone transition in the growth plate. In order to test this hypothesis, we generated transgenic mice misexpressing Sox9 in hypertrophic chondrocytes under the control of a BAC-Col10a1 promoter. The transgenic offspring showed an almost complete lack of bone marrow in newborns, owing to strongly retarded vascular invasion into hypertrophic cartilage and impaired cartilage resorption, resulting in delayed endochondral bone formation associated with reduced bone growth. In situ hybridization analysis revealed high levels of Sox9 misexpression in hypertrophic chondrocytes but deficiencies of Vegfa, Mmp13, RANKL and osteopontin expression in the non-resorbed hypertrophic cartilage, indicating that Sox9 misexpression in hypertrophic chondrocytes inhibits their terminal differentiation. Searching for the molecular mechanism of SOX9-induced inhibition of cartilage vascularization, we discovered that SOX9 is able to directly suppress Vegfa expression by binding to SRY sites in the Vegfa gene. Postnatally, bone marrow formation and cartilage resorption in transgenic offspring are resumed by massive invasion of capillaries through the cortical bone shaft, similar to secondary ossification. These findings imply that downregulation of Sox9 in the hypertrophic zone of the normal growth plate is essential for allowing vascular invasion, bone marrow formation and endochondral ossification.

KW - BAC

KW - Collagen X

KW - Mmp13

KW - Mouse

KW - Runx2

KW - Transgenic

KW - Vegfa

UR - http://www.scopus.com/inward/record.url?scp=77950345356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950345356&partnerID=8YFLogxK

U2 - 10.1242/dev.045203

DO - 10.1242/dev.045203

M3 - Article

C2 - 20179096

AN - SCOPUS:77950345356

VL - 137

SP - 901

EP - 911

JO - Development (Cambridge)

JF - Development (Cambridge)

SN - 0950-1991

IS - 6

ER -